Skip to main content
. 2024 Mar 19;16(6):1204. doi: 10.3390/cancers16061204

Figure 2.

Figure 2

Immunoprofile of each patient. Molecular markers were positive in the following percentage of patients: AR (100%), HER-2/Neu (20%), AE1/3 (67%), S100 (27%), p63 (13%), CK7 (60%), GATA3 (47%), mammaglobin (33%), ER (27%), EMA (40%), SOX10 (20%), BRST-2 (20%), mucicarmine (7%), p40 (13%), GCDFP15 (20%), MNF-116 (20%), CK5/6 (7%), calponin (7%), BCL-1 (7%), GFAP (0%), myosin (0%), PAS (7%), CAM5.2 (13%), and CEA-p (7%). Green = positive; red = negative; white = not tested. Abbreviations: IHC = immunohistochemistry; SDC = salivary duct carcinoma.